Innovative Therapies For Children with Cancer Consortium   Report issue

Foundation Phase 1 Phase 2
Founded: United Kingdom (2003)

Organization Overview

First Clinical Trial
2006
NCT00306202
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Innovative Therapies for Children with Cancer | Innovative Therapies For Children with Cancer Consortium